QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 08:16 UTC · Public disclosure record

← All committees

Committee Lens Senate Committee on Veterans' Affairs

Senate committee · oversees Health

Trades by this committee's members in the sector(s) it oversees — the committee's conflict surface — ranked by Conflict Score. How it's scored.

⚑
This is a transparency signal, not an accusation. A flagged trade is one in a sector this committee oversees. Such trades are frequently entirely legitimate — held in blind trusts, managed by others, or unrelated to any committee action. Nothing here implies wrongdoing; it points to what deserves a closer look.
7
Flagged trades
2 / 6
Members trading in-jurisdiction
$105,004
Est. disclosed volume
83/100
Worst conflict score

Who's trading in-jurisdiction

ConflictMemberTickerCompanyTypeDateAmountSectorSource
83 Thomas Tuberville GILD Gilead Sciences, Inc. BUY PUT 2024-05-10 $1K–$15K Health ↗ eFD
77 Thomas Tuberville HUMA Humacyte, Inc. BUY 2024-03-21 $15K–$50K Health ↗ eFD
77 Thomas Tuberville HUMA Humacyte, Inc. SELL 2024-05-03 $15K–$50K Health ↗ eFD
75 John Boozman LLY Eli Lilly & Co. SELL 2025-11-21 $1K–$15K Health ↗ eFD
75 Thomas Tuberville HUMA Humacyte, Inc. BUY 2024-03-21 $1K–$15K Health ↗ eFD
66 John Boozman BSX Boston Scientific Corp. SELL 2026-06-04 $1K–$15K Health ↗ eFD
63 John Boozman JNJ Johnson & Johnson SELL 2026-08-20 $1K–$15K Health ↗ eFD
About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.